標(biāo)題: Titlebook: Depression and Anxiety in Patients with Chronic Respiratory Diseases; Amir Sharafkhaneh,Abebaw Mengistu Yohannes,Mark E. Book 2017 Springe [打印本頁] 作者: 復(fù)雜 時間: 2025-3-21 17:04
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases影響因子(影響力)
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases影響因子(影響力)學(xué)科排名
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases網(wǎng)絡(luò)公開度
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases被引頻次
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases被引頻次學(xué)科排名
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases年度引用
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases年度引用學(xué)科排名
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases讀者反饋
書目名稱Depression and Anxiety in Patients with Chronic Respiratory Diseases讀者反饋學(xué)科排名
作者: Incise 時間: 2025-3-21 21:25
Daniela Gachago,Andreas H?rfurterfect pattern of chronic diseases on depressive and anxiety disorders and vice versa has now been updated to explain the link between depressive and anxiety symptoms and chronic medical conditions: it posits that depression and anxiety affect behavioral risks for chronic disease, which, in turn, lead作者: fleeting 時間: 2025-3-22 04:27 作者: nocturnal 時間: 2025-3-22 05:27 作者: 熱心 時間: 2025-3-22 12:02 作者: 沙草紙 時間: 2025-3-22 15:12 作者: 沙草紙 時間: 2025-3-22 18:50 作者: 控制 時間: 2025-3-22 23:30
https://doi.org/10.1007/978-3-319-68999-9ioids are beneficial in ameliorating dyspnoea in patients with COPD without series adverse events. However, only a few studies have been conducted to address this question and they are all small in sample size. Additionally, the safety of benzodiazepines for use in patients with severe COPD requires作者: 品嘗你的人 時間: 2025-3-23 04:52 作者: 急性 時間: 2025-3-23 06:30
Depression and Anxiety Across the Age Spectrum,fect pattern of chronic diseases on depressive and anxiety disorders and vice versa has now been updated to explain the link between depressive and anxiety symptoms and chronic medical conditions: it posits that depression and anxiety affect behavioral risks for chronic disease, which, in turn, lead作者: 嚴(yán)厲批評 時間: 2025-3-23 10:28
Diagnostic Tools for Anxiety and Depression, the populations they were designed. However, few, with the exception of the Anxiety Inventory for Respiratory disease (AIR), Brief Assessment Schedule for Depression, Beck Anxiety and Depression Inventory, Generalised Anxiety Inventory and Hospital Anxiety and Depression Scale have been partially v作者: 真實的人 時間: 2025-3-23 14:02 作者: JUST 時間: 2025-3-23 21:02 作者: 飲料 時間: 2025-3-23 23:54 作者: compose 時間: 2025-3-24 04:07 作者: barium-study 時間: 2025-3-24 08:59
Pharmacological Therapy and Anxiolytics in Patients with Respiratory Diseases,ioids are beneficial in ameliorating dyspnoea in patients with COPD without series adverse events. However, only a few studies have been conducted to address this question and they are all small in sample size. Additionally, the safety of benzodiazepines for use in patients with severe COPD requires作者: photophobia 時間: 2025-3-24 14:21 作者: Ganglion-Cyst 時間: 2025-3-24 15:34 作者: capsaicin 時間: 2025-3-24 22:52 作者: sacrum 時間: 2025-3-25 02:44 作者: 謙卑 時間: 2025-3-25 05:50
Hans-Christian Riekhof,Hubert SchülePsychological symptoms and disorders are quite common in patients with COPD. Mental illness increases morbidity in COPD and adds significantly to the economic burden of the disease. Here, we review the pathophysiology, diagnosis, and management of depression and anxiety in COPD.作者: 敵意 時間: 2025-3-25 10:12 作者: 披肩 時間: 2025-3-25 14:09
E-Learning im digitalen Zeitalterms through which patients appraise health-related threats and manage coping resources to combat this threat are discussed. Early identification of psychosocial risk factors including depression and anxiety, as well as coping resources, may significantly influence the course of one’s disease and over作者: 多樣 時間: 2025-3-25 17:01
Daniela Gachago,Andreas H?rfurterure to optimize treatment of both medical disease and mental illness. Anxiety and mood disorders, in particular, are both associated with a wide range of symptoms, with the former tending not to be readily recognized and treated and the latter sometimes mistaken for normal physiologic changes of agi作者: SAGE 時間: 2025-3-25 20:59
Flexible Instruktionsstrategien in L3inically relevant symptoms who are in need of further diagnostic psychiatric assessment. Identifying high numbers of false positives is costly, both financially, and in terms of wasted time for the clinician and the patient. A scale that can efficiently screen patients for anxiety and depression is 作者: 收養(yǎng) 時間: 2025-3-26 03:15 作者: Conscientious 時間: 2025-3-26 06:15 作者: 歹徒 時間: 2025-3-26 09:59
Kourosh Fathi Vajargah,Esmaeil Jafarial and economic challenge to the individual recipient and the caring members of the family. Often, they present as depression and anxiety disorders, usually prior to transplantation and continue into the post-transplant period with potential exacerbation when post-transplant complications occur. The作者: Catheter 時間: 2025-3-26 14:44 作者: Abduct 時間: 2025-3-26 19:41 作者: 秘方藥 時間: 2025-3-26 23:01 作者: Entirety 時間: 2025-3-27 04:48 作者: 灌輸 時間: 2025-3-27 08:34
Kourosh Fathi Vajargah,Esmaeil Jafari like anxiety and depression that need to be treated aggressively. Progression of these symptoms is associated with diminishing quality of life and impairments in activities of daily living. The pathophysiology, pharmacological as well as non-pharmacological management of symptoms will be discussed.作者: Interim 時間: 2025-3-27 10:31
https://doi.org/10.1007/978-1-4939-7009-4depression; anxiety; respiratory; lung disease; cystic fibrosis; asthma作者: Encoding 時間: 2025-3-27 13:53 作者: 過時 時間: 2025-3-27 18:01
Amir Sharafkhaneh,Abebaw Mengistu Yohannes,Mark E.Comprehensive, first-of-its kind title in the field.Covers full range of issues impacting anxiety and depression in patients with pulmonary conditions.Useful resource for clinicians and scientists ali作者: 愛哭 時間: 2025-3-27 22:20 作者: ingrate 時間: 2025-3-28 03:01 作者: 開頭 時間: 2025-3-28 06:59
Depression and Anxiety Across the Age Spectrum,ure to optimize treatment of both medical disease and mental illness. Anxiety and mood disorders, in particular, are both associated with a wide range of symptoms, with the former tending not to be readily recognized and treated and the latter sometimes mistaken for normal physiologic changes of agi作者: 取之不竭 時間: 2025-3-28 14:13
Diagnostic Tools for Anxiety and Depression,inically relevant symptoms who are in need of further diagnostic psychiatric assessment. Identifying high numbers of false positives is costly, both financially, and in terms of wasted time for the clinician and the patient. A scale that can efficiently screen patients for anxiety and depression is 作者: Mortar 時間: 2025-3-28 17:06 作者: Commission 時間: 2025-3-28 20:00
Depression and Anxiety in the Cystic Fibrosis Population,ound to be the driving force of the psychopathology. Proposed causes of depression and anxiety in CF patients include pulmonary symptoms, especially dyspnea and air hunger, as well as vitamin D deficiency, abnormal body image, social stigma, time-consuming treatment regimens, and facing their own mo作者: caldron 時間: 2025-3-29 02:39 作者: Flu表流動 時間: 2025-3-29 03:43
Sleep-Disordered Breathing and Mental Illness,–70?million Americans suffer from a chronic disorder of sleep and wakefulness, hindering daily functioning and adversely affecting health. Insomnia is the most common sleep disorder, followed by sleep apnea and restless legs syndrome (RLS). Obstructive sleep apnea (OSA) is by far the most common for作者: phlegm 時間: 2025-3-29 10:19
The Impact of Comorbidities in Patients with Chronic Respiratory Diseases,is, sleep apnoea syndrome, pneumoconiosis and pleural diseases are common respiratory diseases worldwide. They present similar symptoms such as breathlessness on exertion, excess mucous production, chronic cough and wheezing. When these conditions are not adequately treated and/or become chronic may作者: 柔美流暢 時間: 2025-3-29 12:01
Non-pharmacological Interventions to Manage Depression and Anxiety Associated with Chronic Respiratbut may also involve significant changes or challenges in daily activities, social relationships, self-perception and emotional functioning. The physical symptoms that are persistent in nature and the degenerative trajectories of disease contribute to psychological responses that impact the patients作者: Evacuate 時間: 2025-3-29 19:06
Pharmacological Therapy and Anxiolytics in Patients with Respiratory Diseases,th their daily activities. This section focuses primarily on antidepressant drug trials that have been conducted in patients with COPD and major depression. It will also examine the benefits of anxiolytics for this patient group. Both selective serotonin reuptake inhibitor (SSRI) and tricyclic antid作者: largesse 時間: 2025-3-29 23:35 作者: minimal 時間: 2025-3-30 00:11
Book 2017 management options are outlined. Indeed recent studies indicate a far higher prevalence of depression and anxiety in patients afflicted with chronic respiratory conditions than in patients with other chronic disorders. Unlike other publications in the field of pulmonary disease, .Depression and Anx作者: 咽下 時間: 2025-3-30 04:47 作者: 文字 時間: 2025-3-30 09:36
